Relation between extent of myostatin depletion and muscle growth in mature mice
Authors:
- 1 October 2009
- journal article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 297 (4) , E935-E940
Abstract
Myostatin is a negative regulator of muscle growth and fiber size. Changes in myostatin expression might contribute to changes in muscle mass associated with various conditions, and reducing the amount of active myostatin is a potential strategy for preventing or reversing muscle atrophy. The present study was done to determine the extent to which myostatin levels must decline to induce growth of mature muscles. Myostatin expression was reduced by activating Cre recombinase in adult mice with floxed myostatin genes. The duration of Cre activation varied from 1 to 6 wk, and the residual myostatin mRNA expression after Cre activation varied from 3 to 63% of the normal level. Promyostatin levels declined in parallel with myostatin mRNA. There was no increase in muscle mass over the 3 mo following Cre activation if residual myostatin expression was ≥40% of normal. In mice with <40% of normal myostatin expression, muscle mass increased in proportion to the extent of myostatin depletion. In mice with ≤10% of normal myostatin expression, muscle mass increased ∼25%. Myostatin depletion increased myonuclear domain volumes and the ratio of RNA to myonuclei probably by enhancing DNA transcription rather than by inhibiting RNA decay. There was no evidence that maintenance of the hypertrophy during chronic myostatin deficiency requires altered activity of Akt/mTOR or p38 MAPK signaling pathways. These data suggest that anabolic therapies based on reducing the concentration of active myostatin will be effective only if a very large proportion of the myostatin is removed or inactivated.Keywords
This publication has 44 references indexed in Scilit:
- Myostatin propeptide‐mediated amelioration of dystrophic pathophysiologyThe FASEB Journal, 2005
- Regulation of GDF-8 signaling by the p38 MAPKCellular Signalling, 2005
- TNF‐α acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscleThe FASEB Journal, 2005
- REGULATION OF MUSCLE MASS BY MYOSTATINAnnual Review of Cell and Developmental Biology, 2004
- Resistance Training Alters Plasma Myostatin but not IGF-1 in Healthy MenMedicine & Science in Sports & Exercise, 2004
- Myostatin Gene Expression is Reduced in Humans with Heavy-Resistance Strength Training: A Brief CommunicationExperimental Biology and Medicine, 2003
- Rapid generation of inducible mouse mutantsNucleic Acids Research, 2003
- Inhibition of myostatin in adult mice increases skeletal muscle mass and strengthBiochemical and Biophysical Research Communications, 2003
- Functional improvement of dystrophic muscle by myostatin blockadeNature, 2002
- Dominant negative myostatin produces hypertrophy without hyperplasia in muscleFEBS Letters, 2000